Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures

NCT02389621 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Liver Disease
Thrombocytopenia

Interventions

DRUG: Lusutrombopag
DRUG: Placebo

Sponsor

Shionogi